Important notice

Unavailability of certain services in drug insurance

Some services related to prescription drug insurance coverage are currently unavailable due to technical issues. This situation impacts covered pharmacy services. We are working to resolve the situation as quickly as possible. Thank you for your understanding.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4713 results found.

Example of search result explained

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114144
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114146

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114151

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114225
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114227

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114233
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114228

Amgevita (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114035
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114046

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114041
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114042

Abrilada (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114033

Abrilada (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114034

Amgevita (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114047

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114043
Page 13 of 472

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.